Basecamp Research

Investor: S32

London-based biotech startup Basecamp Research has secured $140 million (£106m) in an oversubscribed Series C funding round to advance its AI-designed therapeutics platform.Summary of transaction details:Value: $140 million (£106m)Sector: Healthcare & BiotechAdvisor: Not disclosedKey Entities: Basecamp Research, S32, Menlo Ventures, Catalio Capital Management, NVIDIA, Roche (André Hoffmann)Location: London, United KingdomNote: The capital injection will accelerate Basecamp Research's development of EDEN, its biological foundation model used to design programmable in vivo cell therapies targeting cancer and autoimmune diseases.

Investor: Anthropic, Nvidia and the UK's sovereign AI fund

Basecamp Research, a London-based start-up specializing in training artificial intelligence on rare biological data, has successfully raised $140 million in a new funding round backed by high-profile investors including Anthropic, Nvidia, and the UK’s sovereign AI fund.Summary of transaction details:Value: $140 millionSector: DeepTech & AIAdvisor: Not disclosedKey Entities: Basecamp Research, Anthropic, Nvidia, UK Sovereign AI FundLocation: London, UKNote: This transaction highlights the intense industry demand for proprietary biological data to train next-generation AI models, enabling faster and more accurate design of advanced cell therapies and medical treatments.

Investor: UK government’s Sovereign AI Fund, Firebrand, S32, Redalpine, the NATO Innovation Fund, Anthropic's Anthology Fund, Catalio, Rockefeller, NVentures, River Capital King Philanthropies, European Tech Collective

Investor: Nvidia

Investor: True Ventures, Feike Sijbesma, Hummingbird Ventures, André Hoffmann, Redalpine, Paul Polman, Singular, S32

Investor: True Ventures, Systemiq Ventures, Hummingbird Ventures, Valo, Blue Horizon Ventures